Laser-Based Odor Test Distinguished Disease Patterns
Researchers have identified distinct spectral signatures in body odor that may help identify various health conditions.
Updated on Sept. 29, 2026 in Diseases — General
Live Poll
Should non-invasive body odor analysis be prioritized over traditional, more invasive medical diagnostic tests?
Scientists successfully used laser-based photoacoustic spectroscopy to detect specific volatile organic compounds in human body swabs. This experimental method correctly distinguished between healthy participants and those with conditions like Parkinson's disease or COVID-19.
Why it matters
Current analytical methods for identifying volatile compounds are often complex and slow, requiring specialized labor. This new approach could eventually simplify diagnostic workflows by enabling faster preliminary screenings for various diseases.
In a preliminary pilot study published in Scientific Reports, researchers analyzed body swabs from 24 participants, including groups with Parkinson's, COVID-19, and healthy controls. The team used photoacoustic spectroscopy to identify unique spectral fingerprints for each group.
The players
Fraunhofer Institute for Integrated Circuits IIS
An applied research organization based in Erlangen, Germany, focused on developing advanced sensor and diagnostic technologies.
Technical University of Dresden
A research university in Germany that collaborates on interdisciplinary health and engineering projects.
The details
The system utilizes widely tunable quantum cascade lasers to target volatile organic compounds naturally emitted by the body. By recording the spectral fingerprint of these compounds from swabs taken at the nasal cavity, navel, and ear, the device can detect subtle chemical variations. These variations act as biomarkers that distinguish the metabolic profiles of healthy individuals from those experiencing specific disease states.
Timeline
The findings were published in Scientific Reports in 2026.
Health Landscape
This research follows a growing pattern of investigating volatile organic compounds as non-invasive biomarkers for systemic disease. It advances the goals of the SMELLODI project, which seeks to integrate olfactory data into future clinical diagnostic tools.
This technology remains in the experimental phase and is not yet available for clinical use or personal screening. If you are concerned about persistent changes in your health or physical symptoms, discuss these observations with your primary care physician.
The takeaway
Laser-based odor analysis represents a potential leap forward in non-invasive, rapid disease screening. While this remains early-stage research, patients should continue to rely on established, physician-led diagnostic tests for any ongoing health concerns.
Further reading
For more on emerging diagnostic technologies, visit Diseases — General.
More information
View the full scientific study publication link for detailed methodology and results.
Source note: This article includes information reported by Informationdienst Wissenschaft e.V. - idw.
Live Poll
Should non-invasive body odor analysis be prioritized over traditional, more invasive medical diagnostic tests?
